BioAro is a Canadian biotech company specializing in precision medicine and personalized healthcare, holds two issued patents and fourteen patent applications. It operates a state-of-the-art genomics lab and data analysis center, focusing on developing proprietary AI and blockchain technologies for genomics.

BioAro offers services such as Whole Genome Sequencing (WGS), microbiome sequencing, and pharmacogenomics. The company also focuses on data encryption and transmission using quantum cryptography and fully homomorphic encryption. Additionally, BioAro has developed an OMICS AI analysis platform and blockchain-based data management systems, offering solutions in cancer screening, gut health, mental health, and more.